Antinuclear Antibody, Anti-DNA Antibody, Anticentromere Antibody, Antiextractable Nuclear Antigen Antibody, Anti-Jo Antibody, and Antiscleroderma Antibody
To view the entire topic, please log in or purchase a subscription.
Nursing Central is an award-winning, complete mobile solution for nurses and students. Look up information on diseases, tests, and procedures; then consult the database with 5,000+ drugs or refer to 65,000+ dictionary terms. Explore these free sample topics:
-- The first section of this topic is shown below --
General
Synonym/Acronym:
Antinuclear antibodies (ANA), anti-DNA (anti-ds DNA), antiextractable nuclear antigens (anti-ENA, ribonucleoprotein [RNP], Smith [Sm], SS-A/Ro, SS-B/La), anti-Jo (antihistidyl transfer RNA [tRNA] synthase), and antiscleroderma (progressive systemic sclerosis [PSS] antibody, Scl-70 antibody, topoisomerase I antibody).
Rationale
To diagnose multiple systemic autoimmune disorders; primarily used for diagnosing systemic lupus erythematosus (SLE).
Patient Preparation
There are no food, fluid, activity, or medication restrictions unless by medical direction.
Normal Findings
Method: ELISA IgG for ANA or indirect fluorescent antibody (IFA) with human epithelial (HEp-2) substrate, IgG titer and pattern; Multiplex immunoassay for anti-DNA, anti-ENA, anti-Scl-70, and anti-Jo-1.
ANA: Titer of 1:80 or less. Anti-DNA, anti-ENA, anti-Jo-1, and anti-Scl-70: Negative. Reference ranges vary widely due to differences in methods, and the testing laboratory should be consulted directly.
Critical Findings and Potential Interventions
N/A
-- To view the remaining sections of this topic, please log in or purchase a subscription --
General
Synonym/Acronym:
Antinuclear antibodies (ANA), anti-DNA (anti-ds DNA), antiextractable nuclear antigens (anti-ENA, ribonucleoprotein [RNP], Smith [Sm], SS-A/Ro, SS-B/La), anti-Jo (antihistidyl transfer RNA [tRNA] synthase), and antiscleroderma (progressive systemic sclerosis [PSS] antibody, Scl-70 antibody, topoisomerase I antibody).
Rationale
To diagnose multiple systemic autoimmune disorders; primarily used for diagnosing systemic lupus erythematosus (SLE).
Patient Preparation
There are no food, fluid, activity, or medication restrictions unless by medical direction.
Normal Findings
Method: ELISA IgG for ANA or indirect fluorescent antibody (IFA) with human epithelial (HEp-2) substrate, IgG titer and pattern; Multiplex immunoassay for anti-DNA, anti-ENA, anti-Scl-70, and anti-Jo-1.
ANA: Titer of 1:80 or less. Anti-DNA, anti-ENA, anti-Jo-1, and anti-Scl-70: Negative. Reference ranges vary widely due to differences in methods, and the testing laboratory should be consulted directly.
Critical Findings and Potential Interventions
N/A
There's more to see -- the rest of this topic is available only to subscribers.